Acute Coronary Syndrome (ACS) represents a spectrum of conditions associated with acute myocardial ischemia. The management of ACS has evolved significantly over the years, with advancements in diagnostic tools, therapeutic modalities, and patient care strategies. This article aims to highlight the most recent advancements and best practices in ACS management.
High-sensitivity cardiac troponin assays have revolutionized the early detection of myocardial injury, allowing for prompt initiation of treatment. Novel imaging techniques, such as coronary computed tomography angiography (CCTA), provide non-invasive visualization of coronary anatomy and plaque characteristics, enhancing diagnostic accuracy.
Contemporary ACS management emphasizes early invasive strategies. Percutaneous coronary intervention (PCI) remains the cornerstone of revascularization, with drug-eluting stents showing superior outcomes. The use of novel antiplatelet agents, such as ticagrelor and prasugrel, has improved the efficacy of dual antiplatelet therapy. Additionally, the emergence of non-vitamin K antagonist oral anticoagulants (NOACs) provides a safer alternative to traditional anticoagulants.
High-quality care for ACS patients extends beyond acute management. Comprehensive discharge planning, including medication review and patient education, is crucial to prevent recurrent events. Multidisciplinary cardiac rehabilitation programs have demonstrated improved patient outcomes, emphasizing the importance of lifestyle modification and secondary prevention measures.
Emerging fields, such as genomics and precision medicine, hold promise for individualized ACS management. Moreover, artificial intelligence and machine learning tools are being explored to predict ACS events and guide therapeutic decisions.
ACS management has witnessed remarkable advancements, from diagnostic modalities to therapeutic interventions and patient care strategies. Continued research and innovation are crucial to further enhance patient outcomes. As healthcare professionals, we must stay abreast of these advancements to deliver the highest quality of care to our patients.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation